Not a lot there. Typical Generex partner. Their listed products are ortho joint related. Nothing on their website indicates they have wound management program expertise. The current line indicates they call on ortho specialists and possibly wellness care clinics. Going to need to be coached up for selling Excellagen to wound care docs.
I do appreciate wound care is an interesting choice for them as a new line of business and the potential is there.
I wonder what their gross sales were for the last few years? Can they afford to purchase $500k worth of product as TT's suggest?
Did we give them shares to partner with us?
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links